OGNNYSEPharmaceutical PreparationsFiscal year ends December 31
Organon & Co.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$13.75−0.01 (-0.07%)
Close on Oct 19, 2026
- Market cap
- $3.72B
- P/E (TTM)
- 17.6
- Dividend yield
- 2.47%
Organon statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Organon | Industry median |
|---|---|---|
| Market Cap | $3.61B | $164.85M |
| Enterprise Value | $11.03B | $87.06M |
| PE Ratio | 17.63 | 19.63 |
| PS Ratio | 0.59 | 3.60 |
| PB Ratio | 3.59 | 2.03 |
| P/FCF Ratio | 6.37 | 17.44 |
| P/OCF Ratio | 4.90 | 13.32 |
Enterprise value
| Measure | Organon | Industry median |
|---|---|---|
| EV / Sales | 1.80 | 2.43 |
| EV / FCF | 19.46 | 20.97 |
Income (trailing twelve months)
| Measure | Organon | Industry median |
|---|---|---|
| Revenue | $6.13B | $57.94M |
| Gross Profit | $3.23B | $90.47M |
| Pretax Income | $491.00M | -$14.45M |
| Net Income | $209.00M | -$22.46M |
| EPS (Diluted) | $0.78 | -$0.83 |
Margins
| Measure | Organon | Industry median |
|---|---|---|
| Gross Margin | 52.7% | 52.3% |
| Pretax Margin | 8.01% | -13.0% |
| Profit Margin | 3.41% | -39.2% |
| FCF Margin | 9.25% | -8.85% |
Returns
| Measure | Organon | Industry median |
|---|---|---|
| Return on Equity (ROE) | 24.0% | -53.1% |
| Return on Assets (ROA) | 1.57% | -41.0% |
Growth
| Measure | Organon | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -2.45% | 6.01% |
| Net Income Growth (YoY) | -70.1% | -37.7% |
| EPS Growth (YoY) | -71.0% | -29.2% |
| FCF Growth (YoY) | -13.8% | 2.34% |
| Revenue Growth (3Y CAGR) | 0.23% | 2.25% |
| Revenue Growth (5Y CAGR) | -0.99% | 6.42% |
| EPS Growth (3Y CAGR) | -41.5% | -0.17% |
| EPS Growth (5Y CAGR) | -39.0% | 3.77% |
Balance sheet
| Measure | Organon | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.13B | $62.42M |
| Total Debt | $8.55B | $120.13M |
| Net Cash (Debt) | -$7.42B | $15.68M |
| Net Cash Per Share | -$28.26 | $0.66 |
| Equity (Book Value) | $1.01B | $48.79M |
| Book Value Per Share | $3.83 | $1.36 |
| Tangible Book Value | -$4.26B | $23.06M |
| Working Capital | $2.50B | $75.77M |
Financial position
| Measure | Organon | Industry median |
|---|---|---|
| Current Ratio | 1.95 | 3.30 |
| Quick Ratio | 1.00 | 2.39 |
| Debt / Equity | 8.50 | 0.51 |
| Debt / FCF | 15.08 | 5.05 |
Cash flow (trailing twelve months)
| Measure | Organon | Industry median |
|---|---|---|
| Operating Cash Flow | $737.00M | -$12.35M |
| Capital Expenditures | -$170.00M | -$1.06M |
| Free Cash Flow | $567.00M | -$20.28M |
| FCF Per Share | $2.16 | -$0.42 |
Efficiency
| Measure | Organon | Industry median |
|---|---|---|
| Asset Turnover | 0.46 | 0.38 |
| Inventory Turnover | 2.07 | 2.67 |
| Revenue Per Employee | $612.70K | $398.96K |
| Profits Per Employee | $20.90K | -$703.34K |
| Employee Count | 10,000 | 74 |
Dividends and yields
| Measure | Organon | Industry median |
|---|---|---|
| Earnings Yield | 5.79% | -22.7% |
| FCF Yield | 15.7% | -9.07% |
| Dividend Yield | 2.47% | 1.82% |
| Shareholder Yield | 2.47% | 0.00% |
| Dividend Per Share | $0.34 | $0.83 |
| Dividend Growth (YoY) | -69.6% | 2.37% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 8.61% | 47.7% |
| FCF Payout Ratio | 3.17% | 51.6% |
Shares
| Measure | Organon | Industry median |
|---|---|---|
| Shares Outstanding | 262,609,000 | 58,179,650 |
| Shares Change (YoY) | 1.39% | 11.1% |
| Shares Change (QoQ) | -0.02% | 0.54% |
| Float | 261,331,000 | 49,173,100 |
| Shares Held by Insiders | 0.49% | 11.6% |
| Shares Held by Institutions | 83.3% | 59.4% |
Taxes
| Measure | Organon | Industry median |
|---|---|---|
| Income Tax | $282.00M | $91.50K |
| Effective Tax Rate | 57.4% | 20.6% |
Scores
| Measure | Organon | Industry median |
|---|---|---|
| Graham Number | $8.20 | $17.36 |
| Graham Upside | -40.4% | -43.6% |
| Altman Z-Score | 1.01 | -0.24 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Organon's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.